Novo CEO pressed by Senate to cut prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into consideration new talks with insurers in regards to the listing selling prices of Wegovy and copyright whenever they pledge to maintain the medicines on their https://zanderyqgvm.bligblogging.com/31205863/what-does-healthcare-news-mean